Chad vs Iran: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Chad
49.0%
in 2025
Iran
54.0%
in 2025
Chad rank
156th
Iran rank
153rd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Chad
- Iran
How they compare
Iran currently reports 54.0% against 49.0% in Chad, a difference of 5.0%.
That makes Iran's figure about 1.1 times Chad's.
Across all 18 years both countries report, Iran has been ahead every year.
Chad ranks 156th and Iran ranks 153rd of 194 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 8.2% | 9.0% | 0.8% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Chad or Iran?
- Iran, at 54.0% against 49.0% in Chad as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Chad and Iran?
- 5.0%, with Iran ahead.
- How many years of comparable data are there for Chad and Iran?
- 18 years are reported by both, from 2008 to 2025.
- How do Chad and Iran rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Chad ranks 156th and Iran ranks 153rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.